According to researchers, social isolation and loneliness significantly increase the risk for premature death.
Researchers from the University of Copenhagen have made a significant discovery as to how schizophrenia may occur. They discovered a genetic defect that causes damage to glial cells may also impair the production of myelin. Researchers believe the lack of myelin may be a significant contributor to the development of schizophrenia in some patients.
According to a new study published in the Journal of Abnormal Psychology, the brains of women with the eating disorder Bulimia Nervosa respond differently to images of sugary and high-fat foods following a stressful situation than those without the disorder. Brain scans reveal bulimic women have decreased blood flow to the precuneus, an area of the brain associated with self-criticism, when presented with images of food following a stressful math test. The findings provide support to current theories that binge eating may provide an alternative focus to negative self-reflections.
Researchers have identified a gene that appears to be implicated in depression in both animal and human models of the disorder. The gene, Slc6a15 can either amplify or reduce stress, depending on its level of activity.
According to researchers, teens who frequently use marijuana have a 159% increased risk of developing recurrent psychotic-like experiences. The new study also reflects on the effects of cannabis use with cognitive development.
A worsening of suicidal thoughts in young people has been linked to sleep disturbances. Participants of the new study who reported lots of variation of when they fall asleep also reported more incidences of insomnia and nightmares, which also lower the threshold for suicidal ideations.
According to researchers, people with insomnia are more likely to report thoughts of death and suicide during a 30 day period than those who don't suffer from sleep disturbances.
According to researchers, Cannabidiol, an active compound in cannabis plants, could help to alleviate cognitive impairment in people with schizophrenia.